FIELD: chemistry.
SUBSTANCE: group of inventions relates to organic chemistry and includes individual compounds presented in the claim, pharmaceutically acceptable salts thereof, a pharmaceutical composition based thereon and use.
EFFECT: pyridine derivatives having selective inhibitory activity on cyclin-dependent kinase 9 (CDK9).
8 cl, 9 tbl, 95 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC COMPOUND, INTERMEDIATE COMPOUND, A METHOD OF ITS PRODUCTION AND ITS USE | 2019 |
|
RU2800153C2 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| PYRIMIDINE COMPOUND WITH CONDENSED RINGS, ITS INTERMEDIATE COMPOUND, METHOD OF PRODUCING, COMPOSITION AND USE | 2016 |
|
RU2732576C2 |
| ATR INHIBITOR AND ITS USE | 2019 |
|
RU2799047C2 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
| LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
| ERBB RECEPTOR INHIBITORS | 2019 |
|
RU2810215C2 |
| NEW TYPE OF CYTIDINE DERIVATIVES AND USE THEREOF | 2015 |
|
RU2684402C2 |
| HYDROXYPURINE COMPOUNDS AND WAYS OF THEIR USE | 2015 |
|
RU2673458C1 |
| DIHYDROPTHERIDINONE DERIVATIVES, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2010 |
|
RU2559881C2 |
